Related Experiment Video
Updated: Nov 9, 2025
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Evaluating the inhibitory priority of Bcl-xL to Bad, tBid and Bax by using live-cell imaging assay
Ge Wu1,2, Zhuang Tu1,2, Fangfang Yang1,2
1Key Laboratory of Laser Life Science, Ministry of Education, College of Biophotonics, South China Normal University, Guangzhou, Guangdong, China.
Abstract:
Molecular regulatory network among the B cell leukemia-2 (Bcl-2) family proteins is a research hotspot on apoptosis. The inhibitory priority of anti-apoptotic Bcl-2 family proteins (such as Bcl-xL) to pro-apoptotic Bcl-2 family proteins (such as Bad, tBid and Bax) determines the outcome of their interactions. Based on over-expression model system, we here evaluate the inhibitory priority of Bcl-xL to Bad, tBid and Bax by using live-cell imaging assay on cell viability. Fluorescence images of living cells co-expressing CFP-Bcl-xL and YFP-Bad or YFP-tBid or YFP-Bax showed that Bcl-xL markedly inhibited Bad/tBid/Bax-mediated apoptosis, revealing that Bcl-xL inhibits the proapoptotic function of Bad, tBid and Bax. In the case of equimolar co-expression of Bad and CFP-Bcl-xL, the inhibition of Bcl-xL on tBid/Bax mediate-apoptosis was completely relieved. Moreover, co-expression of tBid-P2A-CFP-Bcl-xL significantly relieved the inhibition of Bcl-xL on the pro-apoptotic ability Bax, suggesting that Bcl-xL preferentially inhibits the pro-apoptotic ability of Bad over tBid, subsequently to Bax.
Insights
The anti-apoptotic protein Bcl-xL inhibits apoptosis mediated by Bad, tBid, and Bax. Bcl-xL preferentially inhibits Bad over tBid and Bax, impacting cell viability.
Area of Science:
- Molecular biology
- Cell biology
- Biochemistry
Background:
- The B cell leukemia-2 (Bcl-2) family proteins regulate apoptosis.
- Interactions between anti-apoptotic (e.g., Bcl-xL) and pro-apoptotic (e.g., Bad, tBid, Bax) proteins are critical for apoptosis outcomes.
- Understanding the inhibitory hierarchy within the Bcl-2 family is a key research area.
Purpose of the Study:
- To investigate the inhibitory priority of Bcl-xL towards pro-apoptotic proteins Bad, tBid, and Bax.
- To elucidate the molecular mechanisms governing Bcl-xL's regulation of apoptosis.
Main Methods:
- Utilized a cell-based over-expression system.
- Employed live-cell imaging assays to monitor cell viability.
- Co-expressed fluorescently tagged Bcl-xL with YFP-tagged Bad, tBid, or Bax.
Main Results:
- Bcl-xL significantly inhibited apoptosis mediated by Bad, tBid, and Bax.
- When co-expressed equimolarly with Bad, Bcl-xL's inhibition of tBid/Bax-mediated apoptosis was abolished.
- Co-expression of tBid-P2A-CFP-Bcl-xL reduced Bcl-xL's inhibition of Bax-mediated apoptosis.
Conclusions:
- Bcl-xL demonstrates preferential inhibition of Bad over tBid and Bax.
- This hierarchical inhibition by Bcl-xL influences the overall apoptotic pathway.
- Findings provide insights into the regulatory network of Bcl-2 family proteins in apoptosis.
More Related Videos
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
09:58Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
Published on: January 7, 2019